BCNP flashcards
BCNP · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Radiochemical purity
- The fraction of total radioactivity present in the desired chemical form, determined by chromatography and expressed as a percentage of activity in the product peak relative to total activity.
- Radionuclidic purity
- The fraction of total radioactivity attributable to the intended radionuclide, assessed by gamma spectroscopy; contaminating radionuclides must remain below specified limits before a product is released.
- Mo-99 breakthrough limit
- The maximum allowable Mo-99 contamination in Tc-99m eluate is 0.15 kBq per MBq of Tc-99m (0.15 µCi per mCi), tested at each elution using a dose calibrator or dedicated breakthrough detector.
- Tc-99m half-life check
- Technetium-99m has a 6.01-hour physical half-life; measuring activity over time should show roughly a 50% decrease every 6 hours, confirming radionuclidic identity within acceptable tolerance.
- Decay equation
- Activity at time t equals initial activity multiplied by e raised to the negative decay constant times t, where the decay constant is 0.693 divided by the physical half-life.
- Precalibration correction
- When a dose is calibrated for a future time, activity at use equals the calibrated activity multiplied by e raised to the positive decay constant times the elapsed interval, increasing the value.
- Effective half-life
- The combined removal rate from physical decay and biological clearance, calculated so that one divided by effective half-life equals one divided by physical plus one divided by biological half-life.
- Generator elution principle
- Mo-99 bound to an alumina column decays to Tc-99m, which is eluted as sodium pertechnetate with 0.9% sodium chloride; eluate is collected in a shielded vial and assayed.
- Wet column elution schedule
- Wet-column generators should be eluted at least every 24 hours; waiting longer allows Mo-99 and Tc-99m to accumulate, increasing breakthrough risk and radiolytic degradation of the eluate.
- Dose calibrator constancy
- Daily constancy testing uses a long-lived sealed source such as Cs-137 or Co-57; the measured value must fall within the established tolerance, usually plus or minus 10 percent of the reference.
- Dose calibrator accuracy
- Accuracy is verified across multiple radionuclides and geometries by comparing measured activity to decay-corrected reference activity, typically requiring agreement within plus or minus 5 to 10 percent.
- Occupational dose limits
- Annual limits for radiation workers are 50 mSv whole-body effective dose, 150 mSv for the lens, and 500 mSv for extremities and skin; a declared pregnant worker has a 0.5 mSv gestational limit.
- Inverse square law
- Radiation exposure rate from a point source decreases with the square of distance; doubling the distance from a source reduces the exposure rate to one quarter of its original value.
- Laminar flow hood use
- Aseptic radiopharmaceutical preparation occurs in an ISO Class 5 vertical laminar flow hood inside a controlled environment, with syringe shields and lead pigs limiting technologist exposure.
- Tc-99m MDP
- A diphosphonate bone-imaging agent labeled with technetium-99m that localizes to areas of osteoblastic activity and is used for skeletal scintigraphy and metastasis detection.
- Tc-99m sulfur colloid
- A particulate technetium-99m agent taken up by the reticuloendothelial system, used for liver and spleen imaging and for evaluating marrow distribution after intravenous injection.
- Tc-99m MAA
- Macroaggregated albumin labeled with technetium-99m, trapped in pulmonary capillaries after injection, permitting lung perfusion imaging and evaluation of pulmonary embolism.
- Tc-99m DTPA
- A chelating agent labeled with technetium-99m used for renal imaging and glomerular filtration rate measurement; it is cleared primarily by glomerular filtration.
- Tc-99m sestamibi
- A lipophilic cationic technetium-99m complex taken up by myocardial mitochondria, used for myocardial perfusion imaging and parathyroid localization; hepatobiliary clearance is expected.
- Kit preparation records
- Documentation for each radiopharmaceutical kit includes eluate activity and volume, generator identification, time of preparation, radiochemical purity results, and the preparing technologist's identity.
- Visual inspection requirement
- Before administration, each radiopharmaceutical dose is inspected for particulate matter, discoloration, and container integrity; any abnormality requires rejection of the product.
- Decay-in-storage waste
- Radioactive waste is segregated by half-life and held until activity decays to background, typically about ten half-lives, with documentation of survey results before disposal as nonradioactive waste.
- Patient dose assay
- The syringe activity is measured in a dose calibrator before administration, the assay time is recorded, and the prescribed activity is confirmed after decay correction to the administration time.
- Pregnancy and breastfeeding
- Radiopharmaceutical administration during pregnancy or lactation requires justification and counseling; some agents require interruption of breastfeeding for a defined period based on radionuclide excretion.
- Thyroid blocking
- Potassium iodide or perchlorate may be given before certain iodine-containing radiopharmaceuticals to reduce thyroid uptake and protect the gland from unnecessary radiation exposure.
- Radiation safety shielding
- Shielding material and thickness depend on photon energy; lead effectively attenuates technetium-99m emissions at 140 keV, while higher-energy emitters require denser or thicker barriers.
- Sterility testing
- Sterility and bacterial endotoxin testing are required for parenteral radiopharmaceuticals; results may be retrospective for short-lived products while release is based on validated aseptic process controls.
- Eluate assay timing
- Eluate activity is measured in the dose calibrator immediately after collection, and the time is recorded because technetium-99m decays by half approximately every six hours.
- Half-life calculation
- Half-life is determined from activity measurements at two times using the relationship half-life equals 0.693 times elapsed time divided by the natural logarithm of the initial-to-final activity ratio.
- Radiation survey meter
- A calibrated survey meter is used to check work areas, shielding, and waste storage; daily surveys document exposure rates and confirm that areas remain within posted limits.
- Contamination control
- Absorbent bench pads, gloves, and frequent surveys limit radioactive contamination; spills are contained, marked, surveyed, and decontaminated until removable activity is below established limits.
- Dose calibrator geometry
- Sample volume, container type, and position within the dose calibrator affect measured activity; consistent geometry and correct radionuclide selection are required for accurate assay.